← Leaderboards
Sourav Bandyopadhyay
University Of California, San Francisco
$8,349,973
Attributed
$15,620,830
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,620,830 · 7
By mechanism
U01$9,130,560 · 2
R01$3,763,625 · 2
U19$1,819,832 · 1
U54$906,813 · 2
Top collaborators
- Trever G Bivona9 shared
- Michael T Mcmanus9 shared
- Jonathan S. Weissman6 shared
- Nevan J Krogan3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- William A Weiss$31,543,847
- Brian Crompton$6,355,467
- Xiaokun Shu$12,879,545
- Trever G Bivona$22,714,857
- Dana Sarabeth Neel$170,990
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationGeneticCellsIn VivoMutationInsightDrug ResistanceTumorResistanceTechnologyProgramsMolecularSystems BiologyBiologicalCell TypeIn VitroBaseMalignant NeoplasmsMutantOncogenesClustered Regularly Interspaced Short Palindromic RepeatsPathway InteractionsHeterogeneityGrowth
Grant awards (25)
Bay Area Cancer Target Discovery and Development$992,465
U01 · FY2025 · CA
Organoid Acquired Resistance$212,804
U54 · FY2025 · CA · contact PI
Bay Area Cancer Target Discovery and Development$942,785
U01 · FY2024 · CA
Organoid Acquired Resistance$202,165
U54 · FY2024 · CA · contact PI
Bay Area Cancer Target Discovery and Development$976,551
U01 · FY2023 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer$493,346
R01 · FY2023 · CA · contact PI
Organoid Acquired Resistance$208,555
U54 · FY2023 · CA · contact PI
Bay Area Cancer Target Discovery and Development$969,145
U01 · FY2022 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer$493,346
R01 · FY2022 · CA · contact PI
Organoid Acquired Resistance$283,289
U54 · FY2022 · CA · contact PI
The Cancer Target Discovery and Development Network at UCSF$1,026,728
U01 · FY2021 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer$503,415
R01 · FY2021 · CA · contact PI
The Cancer Target Discovery and Development Network at UCSF$1,029,182
U01 · FY2020 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer$502,135
R01 · FY2020 · CA · contact PI
The Cancer Target Discovery and Development Network at UCSF$1,000,618
U01 · FY2019 · CA
The Cancer Target Discovery and Development Network at UCSF$1,158,875
U01 · FY2018 · CA
The Cancer Target Discovery and Development Network at UCSF$1,034,211
U01 · FY2017 · CA
Physical and Genetic Interaction Landscape of the Tyrosine Kinome$440,208
R01 · FY2017 · GM · contact PI
Modeling Core$442,277
U19 · FY2016 · AI · contact PI
Physical and Genetic Interaction Landscape of the Tyrosine Kinome$440,208
R01 · FY2016 · GM · contact PI
Physical and Genetic Interaction Landscape of the Tyrosine Kinome$440,208
R01 · FY2015 · GM
Modeling Core$428,576
U19 · FY2015 · AI · contact PI
Modeling Core$477,315
U19 · FY2014 · AI · contact PI
Physical and Genetic Interaction Landscape of the Tyrosine Kinome$450,759
R01 · FY2014 · GM
Modeling Core$471,664
U19 · FY2013 · AI · contact PI